Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia
ABSTRACT: During the coronavirus disease 2019 (COVID-19) pandemic, patients with humoral immunodeficiency are at higher risk of developing chronic infection and having a negative outcome. Few data are available on therapeutic options for this population. This case report discusses the treatment of disease relapse with remdesivir and monoclonal antibodies in an adult patient with X-linked agammaglobulinaemia..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:110 |
|---|---|
| Enthalten in: |
International Journal of Infectious Diseases - 110(2021), Seite 338-340 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Emanuele Palomba [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| doi: |
10.1016/j.ijid.2021.07.064 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ005466482 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ005466482 | ||
| 003 | DE-627 | ||
| 005 | 20230503025417.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2021.07.064 |2 doi | |
| 035 | |a (DE-627)DOAJ005466482 | ||
| 035 | |a (DE-599)DOAJ5748f0355a18400692f82082450ce247 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Emanuele Palomba |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT: During the coronavirus disease 2019 (COVID-19) pandemic, patients with humoral immunodeficiency are at higher risk of developing chronic infection and having a negative outcome. Few data are available on therapeutic options for this population. This case report discusses the treatment of disease relapse with remdesivir and monoclonal antibodies in an adult patient with X-linked agammaglobulinaemia. | ||
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Monoclonal antibodies | |
| 650 | 4 | |a Neutralizing antibodies | |
| 650 | 4 | |a Remdesivir | |
| 650 | 4 | |a Casirivimab | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a Maria Carrabba |e verfasserin |4 aut | |
| 700 | 0 | |a Gianluca Zuglian |e verfasserin |4 aut | |
| 700 | 0 | |a Laura Alagna |e verfasserin |4 aut | |
| 700 | 0 | |a Paola Saltini |e verfasserin |4 aut | |
| 700 | 0 | |a Valeria Fortina |e verfasserin |4 aut | |
| 700 | 0 | |a Cinzia Hu |e verfasserin |4 aut | |
| 700 | 0 | |a Alessandra Bandera |e verfasserin |4 aut | |
| 700 | 0 | |a Giovanna Fabio |e verfasserin |4 aut | |
| 700 | 0 | |a Andrea Gori |e verfasserin |4 aut | |
| 700 | 0 | |a Antonio Muscatello |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t International Journal of Infectious Diseases |d Elsevier, 2015 |g 110(2021), Seite 338-340 |w (DE-627)DOAJ000043923 |x 18783511 |7 nnns |
| 773 | 1 | 8 | |g volume:110 |g year:2021 |g pages:338-340 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijid.2021.07.064 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/5748f0355a18400692f82082450ce247 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1201971221006196 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1201-9712 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 110 |j 2021 |h 338-340 | ||